1-17 of 17
Maria R. Baer, M.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Pim Kinase Inhibitor SGI-1776 Chemosensitizes Multidrug Resistant Cells by Both Inhibiting Drug Transport by ABCB1 and ABCG2 and Decreasing ABCB1 and ABCG2 Surface Expression On Cells That Overexpress Pim-1.

Karthika Natarajan, PhD, Jasjeet Bhullar, PhD, Suneet Shukla, PhD, Mehmet Burcu, BS, Suresh V. Ambudkar, PhD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 2462.
https://doi.org/10.1182/blood.V120.21.2462.2462
Published: 2012
Journal Articles

Short Survival and High Rates of Transformation Prevail in Chronic Myelomonocytic Leukemia Despite Hypomethylating Agent Therapy.

Emily J. Vannorsdall, M.D., Vu H. Duong, M.D., Xinyi Ng, B.S., Dan P. Zandberg, M.D., Michael L. Tidwell, C.R.N.P., Amy J. Davidoff, M.S., Ph.D., Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 2800.
https://doi.org/10.1182/blood.V120.21.2800.2800
Published: 2012
Journal Articles

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis.

Amy J. Davidoff, M.S., Ph.D., Franklin Hendrick, B.S., Bruce C. Stuart, PhD, Amer M. Zeidan, MD, Rahul Shenolikar, PhD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 3176.
https://doi.org/10.1182/blood.V120.21.3176.3176
Published: 2012
Journal Articles

Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.

Amer M. Zeidan, MD, Maria R. Baer, M.D., Steven D. Gore, MD, Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3178.
https://doi.org/10.1182/blood.V120.21.3178.3178
Published: 2012
Journal Articles

Association Between FDA Safety Warnings, CMS Coverage Restrictions and Adherence to Guidelines for ESA Use in Patients with Myelodysplastic Syndromes

Franklin Hendrick, B.S., Amy J. Davidoff, M.S., Ph.D., Amer M. Zeidan, MD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 971.
https://doi.org/10.1182/blood.V120.21.971.971
Published: 2012
Journal Articles

Lenalidomide Performance in the Real World: Patterns of Utilization and Effectiveness in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Steven D. Gore, MD, Diane L. McNally, BSPharm, M.S., Maria R. Baer, M.D., Franklin Hendrick, B.S., Dalia Mahmoud, MBA, Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3837.
https://doi.org/10.1182/blood.V120.21.3837.3837
Published: 2012
Journal Articles

Lack of Response of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) to Decitabine After Failure of Azacitidine

Bhavana Bhatnagar, DO, Dan P. Zandberg, M.D., Emily J. Vannorsdall, M.D., Alison P. Duffy, Pharm.D., Michael L. Tidwell, C.R.N.P., Yi Ning, Qing Chen, M.D., Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 3858.
https://doi.org/10.1182/blood.V120.21.3858.3858
Published: 2012
Journal Articles

Maintenance Therapy with Decitabine in Younger Adults with Acute Myeloid Leukemia (AML) in First Remission: A Phase II Cancer and Leukemia Group B Study (CALGB 10503, Alliance)

William Blum, MD, Ben Sanford, Rebecca B Klisovic, MD, Daniel J. DeAngelo, MD, PhD, Geoffrey Uy, MD, Bayard L. Powell, MD, Wendy Stock, MD, Maria R. Baer, M.D., Jonathan E. Kolitz, MD, Meir Wetzler, MD, Eva Hoke, Clara D. Bloomfield, MD, Susan Geyer, PhD, Guido Marcucci, MD, Richard M. Stone, MD, Richard A. Larson, MD
Journal: Blood
Blood (2012) 120 (21): 44.
https://doi.org/10.1182/blood.V120.21.44.44
Published: 2012
Journal Articles

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Franklin Hendrick, B.S., Erika Friedmann, PhD, Steven D. Gore, MD, Maria R. Baer, M.D., Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 426.
https://doi.org/10.1182/blood.V120.21.426.426
Published: 2012
Journal Articles

Tertiary Center Referral Patterns for Myelodysplastic Syndrome (MDS) Patients Are Suggestive of Age and Race Disparities

Dan P. Zandberg, M.D., Jason Bierenbaum, M.D., Ivana Gojo, M.D., Michael L. Tidwell, C.R.N.P., Yi Ning, Ph.D., Xianfeng Frank Zhao, M.D., Ph.D., Amy J. Davidoff, M.S., Ph.D., Maria R. Baer, M.D.
Journal: Blood
Blood (2010) 116 (21): 1881.
https://doi.org/10.1182/blood.V116.21.1881.1881
Published: 2010
Journal Articles

Inhibition of the Serine/Threonine Kinase Pim-1 Has Anti-Proliferative Effects In Acute Myeloid Leukemia (AML) and Sensitizes Multidrug Resistant Cells to Chemotherapy

Karthika Natarajan, Ph.D., Mehmet Burcu, B.S., Maria R. Baer, M.D.
Journal: Blood
Blood (2010) 116 (21): 1832.
https://doi.org/10.1182/blood.V116.21.1832.1832
Published: 2010
Journal Articles

Access to Care, Race and Education Are Key Determinants of Erythropoietin Stimulating Agent (ESA) Use In Myelodysplastic Syndromes (MDS).

Amy J. Davidoff, PhD, M.S., Sheila Weiss Smith, PhD, Maria R Baer, M.D., Xuehua Ke, M.A., Jason M Bierenbaum, M.D., Franklin Hendrick, B.S., Diane L. McNally, BSPharm, M.S., Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 3815.
https://doi.org/10.1182/blood.V116.21.3815.3815
Published: 2010
Journal Articles

Subcutaneous Omacetaxine (OM) Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients Following Multiple Tyrosine Kinase Inhibitor (TKI) Failure

Jorge E. Cortes, MD, Meir Wetzler, MD, Jeff Lipton, MD, FRCPC, Franck E Nicolini, MD, PhD, Michele Baccarani, MD, Maria R Baer, M.D., H. Jean Khoury, David Cram, PharmD, Eric D. Humphriss, BA, Annie-Claude Benichou, MD, Adam Craig, MD, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 2290.
https://doi.org/10.1182/blood.V116.21.2290.2290
Published: 2010
Journal Articles

The Serine/Threonine Kinase Pim-1 Stabilizes 130 Kilodalton FLT3 and Promotes Aberrant Signaling through STAT5 in Acute Myeloid Leukemia Cells with FLT3 Internal Tandem Duplication: Synergistic Apoptosis Induction by Pim-1 and FLT3 Inhibitors.

Yingqiu Xie, Ph.D., Mehmet Burcu, B.S., Maria R. Baer, M.D.
Journal: Blood
Blood (2009) 114 (22): 942.
https://doi.org/10.1182/blood.V114.22.942.942
Published: 2009
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Compared to Chemotherapy Only in Acute Myeloid Leukemia (AML) Patients 60 Years and Older: A Center for International Blood and Marrow Transplantation Research (CIBMTR)/ Cancer and Leukemia Group B (CALGB) Study.

Sherif Farag, MD, PhD, Kati Maharry, MAS, Waleska S. Perez, MPH, Mei-Jie Zhang, PhD, John F. DiPersio, MD, PhD, Donald Bunjes, MD, Guido Marcucci, M.D., Maria R. Baer, M.D., Richard A. Larson, MD, Martin Tallman, MD, Clara D. Bloomfield, M.D., Daniel J. Weisdorf, MD
Journal: Blood
Blood (2009) 114 (22): 657.
https://doi.org/10.1182/blood.V114.22.657.657
Published: 2009
Journal Articles

Clinical and Pathological Presentation of T-Cell Large Granular Lymphocyte Proliferations (T-LGL): A Single Institution Experience.

Minoo Battiwalla, M.D., Paul K. Wallace, Ph.D., Laurie A. Ford, B.S., Maria R. Baer, M.D.
Journal: Blood
Blood (2004) 104 (11): 3865.
https://doi.org/10.1182/blood.V104.11.3865.3865
Published: 2004
Journal Articles

Characterization of the Resistance Mechanisms of HL60 Leukemia Cell Derivatives to Apo2L/TRAIL.

Jinrong Cheng, M.S, Bonnie L. Hylander, Ph.D, Maria R. Baer, M.D, Elizabeth A. Repasky, Ph.D
Journal: Blood
Blood (2004) 104 (11): 3412.
https://doi.org/10.1182/blood.V104.11.3412.3412
Published: 2004